You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
國藥控股(01099.HK)建議重選李智明、於清明及劉勇為執行董事
格隆匯 08-21 21:45

格隆匯8月21日丨國藥控股(01099.HK)公告,鑑於第四屆董事會的任期將於2020年9月20日屆滿,其於2020年8月21日召開的董事會會議上決議建議重選李智明先生、於清明先生及劉勇先生為第五屆董事會執行董事;重選陳啟宇先生、馬平先生、胡建偉先生、鄧金棟先生、文德鏞先生、關曉暉女士及馮蓉麗女士為第五屆董事會非執行董事;及重選卓福民先生及陳方若先生為第五屆董事會獨立非執行董事。此外,董事會亦於該會議上建議新委任李培育先生、吳德龍先生及俞衞鋒先生為第五屆董事會獨立非執行董事。

鑑於第四屆監事會的任期亦將於2020年9月20日屆滿,監事會於2020年8月21日召開的監事會會議上決議建議重選李曉娟女士為第五屆監事會股東代表監事;監事會亦於該會議上建議新委任吳以芳先生及劉正東先生為第五屆監事會獨立監事。

第四屆董事會獨立非執行董事餘梓山先生、陳偉成先生及劉正東先生將於公司股東大會批准委任第五屆董事會董事時退任;第四屆監事會獨立監事姚方先生及陶武平先生將於公司股東大會批准委任第五屆監事會監事時退任。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account